Lacticaseibacillus paracasei LPC09 (DSM 24243) (formerly Lactobacillus paracasei)

Gastroenterology
GUT MICROBIOME DYSBIOSIS
Inhibits pathogenic E. coli, E. faecalis, K. Pneumoniae, S. aureus and/or P. aeruginosa [in vitro]
Blend
Finished dosage form
a) Deidda F, et al. How Probiotics may Kill Harmful Bacteria: The in vitro Activity against Some Haemolytic Strains. J Prob Health, 2020. Vol. 8 Iss.2 No: 216. DOI: 10.35248/2329-8901.20.8.216
For information on blends containing LPC09, see the following Blends pages:
- CELIAFLORA™ ADULTS
- BIFICIST®
- BIFIPROST®
Urology
Oxalate metabolism
Supports healthy oxalate metabolism [in vitro]
Blend
Finished dosage form
a) Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.
For information on blends containing LPC09, see the following Blends pages:
- CELIAFLORA™ ADULTS
- CELIAFLORA™ IBD ADULTS
- BIFICIST®
- BIFIPROST®